Education
About Us
Working with TipRanks
Follow Us
4DMedical Ltd (AU:4DX)
ASX:4DX
Total Valuation
4DMedical Ltd has a market cap or net worth of AU$830.45M. The enterprise value is AU$104.24M.
Market CapAU$830.45M
Enterprise ValueAU$104.24M
Share Statistics
4DMedical Ltd has 515,808,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding515,808,500
Owned by Insiders0.69%
Owned by Institutions―
Financial Efficiency
4DMedical Ltd’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -51.96%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-51.96%
Return on Capital Employed (ROCE)-0.63
Revenue Per Employee40.37K
Profits Per Employee-207.38K
Employee Count145
Asset Turnover0.06
Inventory Turnover0.51
Valuation Ratios
The current PE Ratio of 4DMedical Ltd is ―. 4DMedical Ltd’s PEG ratio is -0.06.
PE Ratio―
PS Ratio8.81
PB Ratio0.80
Price to Fair Value0.80
Price to FCF-1.49
Price to Operating Cash Flow-26.17
PEG Ratio-0.06
Income Statement
In the last 12 months, 4DMedical Ltd had revenue of 5.85M and earned -30.07M in profits. Earnings per share was -0.14.
Revenue5.85M
Gross Profit5.39M
Operating Income-47.50M
Pretax Income-35.36M
Net Income-30.07M
EBITDA-45.82M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was -24.31M and capital expenditures -61.63K, giving a free cash flow of -24.37M billion.
Operating Cash Flow-24.31M
Free Cash Flow-24.37M
Free Cash Flow per Share-0.05
Dividends & Yields
4DMedical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change245.83%
50-Day Moving Average1.78
200-Day Moving Average0.79
Relative Strength Index (RSI)52.24
Average Volume (3m)10.77M
Important Dates
4DMedical Ltd upcoming earnings date is Mar 4, 2026, Before Open (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
4DMedical Ltd as a current ratio of 0.89, with Debt / Equity ratio of 6.71%
Current Ratio0.89
Quick Ratio0.84
Debt to Market Cap0.02
Net Debt to EBITDA0.06
Interest Coverage Ratio-186.22
Taxes
In the past 12 months, 4DMedical Ltd has paid -5.29M in taxes.
Income Tax-5.29M
Effective Tax Rate0.15
Enterprise Valuation
4DMedical Ltd EV to EBITDA ratio is -1.07, with an EV/FCF ratio of -1.42.
EV to Sales8.37
EV to EBITDA-1.07
EV to Free Cash Flow-1.42
EV to Operating Cash Flow-1.42
Balance Sheet
4DMedical Ltd has AU$6.88M in cash and marketable securities with AU$4.31M in debt, giving a net cash position of AU$2.57M billion.
Cash & Marketable SecuritiesAU$6.88M
Total DebtAU$4.31M
Net CashAU$2.57M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share-AU$0.01
Margins
Gross margin is 92.54%, with operating margin of -811.49%, and net profit margin of -513.72%.
Gross Margin92.54%
Operating Margin-811.49%
Pretax Margin-604.09%
Net Profit Margin-513.72%
EBITDA Margin-782.79%
EBIT Margin-822.76%
Analyst Forecast
The average price target for 4DMedical Ltd is AU$2.38, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$2.38
Price Target Upside36.78% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast55.91%
EPS Growth Forecast22.60%